SIRION BIOTECH EXPANDS US PRESENCE IN MASSACHUSETTS.

 
FREE EXCERPT

SIRION Biotech International Inc., a wholly-owned subsidiary of SIRION Biotech GmbH in Germany has opened a new office in Cambridge, Massachusetts. SIRION hosted a Bavarian-themed grand opening event. World renowned gene cell therapy developers and viral vector experts talked about the importance of the right viral vectors in making gene therapy a reality. Gene therapy has seen strong clinical advancement, and SIRION is becoming a partner of choice in this growing sector as demonstrated by recent deals with Denali Therapeutics, Orchard Therapeutics, and an additional, undisclosed alliance with a major public company that is advancing the discipline.

As transduction and manufacturing efficiencies are critical issues in gene therapy, SIRION's viral vectors are essential to the success of their partnering companies, said Dieter Lingelbach, Chief Operating Officer of SIRION Biotech. Dieter continued, Since two-thirds of SIRION's revenue already comes from US customers and partners, opening an office in a Life Science hub like Cambridge, Massachusetts further...

To continue reading

FREE SIGN UP